Skip to content
Bone WizardryMEDICAL EDUCATION
⌘ KStart free
Back
On this page
0%

MICRO

Pneumonic Plague

Pneumonic plague kills within 24 hours of symptom onset unless antibiotics are started within the first 18 hours -- after that, mortality approaches 100 percent even with appropriate therapy.

From Y. pestis inhalation to fulminant pneumonia
  • Identify pneumonic plague by its hallmark presentation: acute fever, hemoptysis, fulminant pneumonia, and rapid respiratory failure within 24 hours
  • Explain how Yersinia pestis uses the type III secretion system and Yop effectors to evade phagocytosis and suppress host cytokine signaling
  • Distinguish pneumonic plague from bubonic, septicemic, and meningeal forms by route of acquisition and clinical features
  • Select first-line antibiotics (streptomycin, gentamicin, doxycycline, or fluoroquinolones) based on availability and patient factors
  • Apply post-exposure prophylaxis protocols for close contacts and healthcare workers exposed to respiratory secretions

Quick check

A 35-year-old man who works as a wildlife biologist in New Mexico develops sudden high fever, severe headache, and a productive cough with bright red blood 48 hours after performing a necropsy on a dead prairie dog. His temperature is 39.8 C, heart rate 128, blood pressure 88/52, respiratory rate 34, oxygen saturation 86 percent on room air. Chest radiograph shows bilateral infiltrates with hilar adenopathy. Sputum Gram stain reveals numerous gram-negative coccobacilli.

Which treatment principle is most appropriate now?

The organism behind the pandemic

Yersinia pestis is a gram-negative coccobacillus with a bipolar staining pattern that gives it a safety-pin appearance on Wright or Giemsa stain.

Yersinia pestis is a facultative intracellular gram-negative coccobacillus from the Enterobacteriaceae family. It is the agent of three historical pandemics including the Black Death. On Wright or Giemsa stain the organism shows characteristic bipolar staining with dark-staining poles and a clear central zone, resembling a safety pin. The organism grows slowly on standard culture media and may be misidentified by automated systems.

The natural reservoir is wild rodents including prairie dogs, ground squirrels, and rats. Transmission to humans occurs through the bite of infected fleas (Xenopsylla cheopis), direct contact with infected animal tissues, or inhalation of aerosolized respiratory droplets from a coughing human or animal. In the United States, endemic foci exist in the Southwest including New Mexico, Arizona, Colorado, and California.

Pneumonic plague is transmitted by respiratory droplets and can progress rapidly to respiratory failure and shock when untreated. It may follow direct inhalation or hematogenous spread from bubonic or septicemic disease.

Explore the transmission routes and endemic regions of Yersinia pestis.

The safety-pin appearance on stain is pathognomonic for Yersinia pestis but culture confirmation is required; never delay antibiotics while waiting for culture results.

The virulence arsenal

Yersinia pestis carries a plasmid-encoded type III secretion system that injects Yop effector proteins directly into host immune cells.

Key factors that enable immune evasion and tissue invasion

The F1 capsular antigen is a protein-polysaccharide layer that inhibits phagocytosis by preventing complement deposition on the bacterial surface. Strains lacking F1 are less virulent. The V antigen (LcrV) is a multifunctional protein that acts as a needle-tip component of the type III secretion system and also has immunosuppressive properties by inducing IL-10 production.

The type III secretion system (T3SS) is a molecular syringe that injects Yop (Yersinia outer protein) effectors directly into the cytoplasm of host macrophages, neutrophils, and dendritic cells. This injection paralyzes the host immune response at the point of contact. Key Yop effectors include YopH, a tyrosine phosphatase that disrupts phagocytosis signaling; YopJ, which inhibits NF-kB and MAPK pathways to suppress cytokine production; and YopE, which disrupts the actin cytoskeleton by acting as a GTPase-activating protein.

The plasminogen activator (Pla) is a surface protease that cleaves plasminogen to plasmin, promoting fibrinolysis and bacterial dissemination through tissue planes. Pla also degrades complement proteins C3 and C5, further inhibiting opsonization. These virulence factors together allow Yersinia pestis to survive in the bloodstream and reach high bacterial loads before the host mounts an effective response.

Arrange the sequence of Yersinia pestis infection from inhalation to immune evasion.

  1. 1Alveolar deposition and epithelial invasion

    Inhaled Y. pestis attaches to and invades alveolar epithelium.

Yersinia pestis does not just evade the immune system -- it actively disarms immune cells at the moment of contact using the T3SS molecular syringe.

Four clinical forms of plague

The same organism produces four distinct clinical syndromes depending on the route of inoculation and host immune response.

Bubonic plague accounts for over 80 percent of cases. After a flea bite, Yersinia pestis travels through lymphatics to regional lymph nodes, where it causes massive inflammatory lymphadenitis. The resulting bubo is an exquisitely painful, immobile, fluctuant lymph node mass, most often in the groin, axilla, or cervical chain. The classic bubo is the key distinguishing feature.

Pneumonic plague presents with abrupt onset of fever, chills, headache, chest pain, dyspnea, and hemoptysis. The hallmark is a fulminant pneumonia that progresses to respiratory failure within 18-24 hours. Chest imaging shows bilateral alveolar infiltrates, hilar adenopathy, and may show cavitation. Without antibiotics within 18 hours of symptom onset, mortality approaches 100 percent.

Septicemic plague can occur without bubo formation and presents with overwhelming bacteremia, high fever, hypotension, disseminated intravascular coagulation, purpura, and acral necrosis. Meningeal plague is a rare form that develops when the organism crosses the blood-brain barrier, usually secondary to inadequately treated bubonic plague, and presents with neck rigidity, altered mental status, and CSF pleocytosis.

Compare the four clinical forms of plague across their key features.

Bubonic plague

Flea bite, painful bubo, 50-60% mortality untreated. Incubation 2-6 days.

The absence of a bubo does not rule out plague -- septicemic plague bypasses lymph node involvement entirely.

Antibiotics that save lives

The choice of antibiotic matters less than the speed of administration. Once started, the standard regimen is 10-14 days.

Bubonic, pneumonic, septicemic, and meningeal

Treatment begins as soon as plague is suspected. CDC first-line options in the United States include fluoroquinolones, gentamicin, and streptomycin, selected according to severity, pregnancy, age, renal function, allergies, and public-health guidance.

Doxycycline 100 mg IV twice daily (or 200 mg once daily) is a highly effective alternative, particularly for mass casualty scenarios because it can be given orally or intravenously. Fluoroquinolones including ciprofloxacin 400 mg IV or 750 mg orally twice daily and levofloxacin have demonstrated excellent efficacy in animal models and human case series. The CDC recommends fluoroquinolones as a first-line option.

Chloramphenicol is reserved for plague meningitis because of its excellent CNS penetration. It is not first-line for uncomplicated pneumonic plague. All regimens are continued for 10-14 days total, and treatment should not be delayed for diagnostic confirmation. If plague is suspected, start empiric therapy immediately after blood and sputum cultures are collected.

Which antibiotic regimens are first-line for pneumonic plague?

Never delay antibiotics for diagnostic confirmation. If pneumonic plague is suspected, start gentamicin, doxycycline, or a fluoroquinolone within minutes, not hours.

Post-exposure prophylaxis and infection control

Pneumonic plague is a bioterrorism category A agent and requires immediate public health reporting.

Close contacts of a patient with pneumonic plague require post-exposure prophylaxis regardless of whether they are symptomatic. A close contact is defined as anyone who was within 2 meters of the patient without a mask, or who had direct contact with respiratory secretions. Healthcare workers who used standard droplet precautions (mask, gown, gloves, eye protection) do not require prophylaxis.

The recommended PEP regimen is doxycycline 100 mg twice daily or ciprofloxacin 500 mg twice daily for 7 days. PEP should be started as soon as possible after exposure, ideally within 24 hours. Exposed individuals should also monitor their temperature twice daily and seek evaluation immediately if they develop fever or respiratory symptoms.

Suspected pneumonic plague requires standard and droplet precautions and immediate notification of local or state public health authorities. Airborne isolation is not routinely required unless an aerosol-generating procedure creates an additional risk.

Open each infection control measure to reveal its details.

Close contact definition

Within 2 meters without mask or direct contact with respiratory secretions.

PEP regimen

Doxycycline 100 mg PO BID or ciprofloxacin 500 mg PO BID x 7 days for all close contacts.

Droplet precautions

Negative pressure room, mask, gown, gloves, eye protection. Continue 48 hours after antibiotic start and until sputum culture negative.

Public health reporting

Immediately notifiable to local, state, and CDC. Bioterrorism category A agent.

PEP is doxycycline or ciprofloxacin for 7 days for all close contacts; healthcare workers using standard droplet precautions do not need PEP.

The differential and the trap

Pneumonic plague mimics severe community-acquired pneumonia, tularemia, and inhalational anthrax, but the speed of progression and hemoptysis narrow the field.

The most dangerous trap is mistaking pneumonic plague for bacterial community-acquired pneumonia. Typical CAP progresses over days; pneumonic plague progresses over hours. Hemoptysis is uncommon in CAP but is a hallmark of plague. Bilateral hilar adenopathy is also more specific to plague than to typical CAP.

Tularemia (Francisella tularensis) can also present with typhoidal or pneumonic forms after inhalation, but it typically has a more indolent course and does not cause the same explosive hemorrhagic pneumonia. Inhalational anthrax (Bacillus anthracis) causes hemorrhagic mediastinitis rather than pneumonia, with mediastinal widening on chest radiograph rather than hilar adenopathy.

The epidemiologic context is critical. Plague should be suspected in any patient with acute febrile respiratory illness who has spent time in an endemic area, handled rodents or other wild animals, or has a known rodent die-off in the area. A history of flea bites, camping, or wildlife exposure should be actively sought.

Rank each condition by the speed of progression from symptom onset to respiratory failure.

Hours, not days, is the timeline that separates pneumonic plague from community-acquired pneumonia.

Recognize, treat, and contain plague

Five cases move through exposure recognition, clinical classification, antibiotic selection, infection control, and public health response for plague.

A 24-year-old veterinary assistant in Arizona develops fever, cough, and pleuritic chest pain one day after treating a sick cat. Her temperature is 39.2 C, heart rate 122, respiratory rate 30, blood pressure 95/60, oxygen saturation 89% on room air. She has a productive cough with blood-tinged sputum. Chest radiograph shows a right upper lobe infiltrate with hilar adenopathy. She has no skin lesions or lymphadenopathy. Her leukocyte count is 18,000 per microliter.

What is the most likely diagnosis and the required immediate action?

Medically reviewed

Dr. Fatima Ali, DO

Dr. Fatima Ali, DO

PGY-1 Resident Physician in Psychiatry

University Hospitals, Columbia

DO from Kansas City University

Resident physician and founding medical reviewer at Bone Wizardry, focused on clinical accuracy, clear diagnostic reasoning, and practical board-oriented teaching across the curriculum.

Languages: English, Urdu

Primary reviewerFull physician profile

Medically reviewed

Sources

  1. Clinical Care of Plague2024
  2. Antimicrobial Treatment and Prophylaxis of Plague: Recommendations for Naturally Acquired Infections and Bioterrorism Response2021

Bone Wizardry is a study resource for medical students. It is not medical advice.

Search Bone Wizardry

Quick links
↑ ↓ Navigate Enter Open Esc CloseBrowse the library ↗